BioTalk

A UK judge has for the first time granted a website blocking injunction targeting counterfeit and unlicensed prescription-only medicines....

There is a fair chance that the seedless mandarins in your local supermarket recently featured in a case at the English High Court. The...

The ICO is currently consulting on updates to its guidance on the Research, Archiving and Statistics (RAS) provisions, following the Data...

The United States has introduced sweeping new tariffs targeting patented pharmaceutical products and their ingredients, with duties set...

  1. Introduction On 12 December 2025, the European Data Protection Board (EDPB) hosted a focused stakeholder event to gather input for...

Our foreign clients often ask us about the statute of limitations for personal injury under French law. While the question may appear...

Understanding the impact of the European Accessibility Act on Medical Devices The European Accessibility Act (Directive (EU) 2019/882)...

Recent German court decisions have fundamentally shifted the risk landscape for generic and biosimilar companies facing second medical...

The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...

England’s National Health Service (NHS) is seen as one of the world’s most ambitious and comprehensive healthcare systems, but has been...

This article is part of a series covering updates to the proposed European Union (EU) pharmaceutical legislation reform, known as the...

On 12 December 2024, the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024  were laid before Parliament. These were...

The EPO Board of Appeal (“BoA”) recently rejected a patent application relating to pig-human chimeras, concluding that the invention was...

On 11 December 2024, the MHRA published an updated roadmap for the future of the regulatory framework for medical devices in the UK,...

The amount of capital required to develop and bring a drug to market is significant. It is estimated that it costs US$1-2 billion to...

There is a huge cost of bringing a pharmaceutical product to market, with estimates ranging from US$1-2 billion to take a product from...